NHI:NYE-National Health Investors Inc. (USD)

EQUITY | REIT - Healthcare Facilities | New York Stock Exchange

Last Closing

USD 73.44

Change

+0.97 (+1.34)%

Market Cap

USD 2.83B

Volume

0.27M

Analyst Target

USD 61.22
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

National Health Investors Inc is a real estate investment trust. The Company is engaged in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing & medical investments.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-27 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+1.37 (+0.90%)

USD 97.26B
VTR Ventas Inc

-0.23 (-0.36%)

USD 28.94B
DOC Healthpeak Properties Inc

+0.11 (+0.63%)

USD 11.70B
CTRE CareTrust REIT Inc.

-0.08 (-0.28%)

USD 5.46B
AHR American Healthcare REIT, Inc.

+0.13 (+0.37%)

USD 5.17B
LTC LTC Properties Inc

+0.17 (+0.48%)

USD 1.65B
UHT Universal Health Realty Income..

+0.62 (+1.60%)

USD 0.53B
CHCT Community Healthcare Trust Inc

+0.13 (+0.80%)

USD 0.45B
GMRE-PA Global Medical REIT Inc

+0.05 (+0.20%)

USD 0.40B
MPW Medical Properties Trust Inc

N/A

N/A

ETFs Containing NHI

DIV Global X SuperDividend U... 0.00 % 0.46 %

+0.08 (+0.46%)

USD 0.63B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.97% 67% D+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.97% 53% F 76% C+
Trailing 12 Months  
Capital Gain 13.37% 67% D+ 78% C+
Dividend Return 4.17% 27% F 67% D+
Total Return 17.54% 67% D+ 80% B-
Trailing 5 Years  
Capital Gain 27.04% 77% C+ 49% F
Dividend Return 30.98% 62% D 75% C
Total Return 58.02% 69% C- 53% F
Average Annual (5 Year Horizon)  
Capital Gain 4.91% 60% D- 56% F
Dividend Return 10.89% 53% F 67% D+
Total Return 5.98% 67% D+ 88% B+
Risk Return Profile  
Volatility (Standard Deviation) 21.40% 53% F 46% F
Risk Adjusted Return 50.87% 60% D- 67% D+
Market Capitalization 2.83B 50% F 73% C

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 16.40 89% 33%
Price/Book Ratio 2.37 44% 35%
Price / Cash Flow Ratio 16.29 50% 23%
Price/Free Cash Flow Ratio 16.82 56% 23%
Management Effectiveness  
Return on Equity 10.31% 100% 62%
Return on Invested Capital 7.15% 90% 54%
Return on Assets 4.56% 100% 71%
Debt to Equity Ratio 59.63% 30% 54%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector